These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26165449)

  • 1. Optimal management of resectable gastric adenocarcinoma.
    Buscariollo DL; Mamon HJ
    Expert Rev Anticancer Ther; 2015; 15(8):931-41. PubMed ID: 26165449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric adenocarcinoma surgery and adjuvant therapy.
    Patel SH; Kooby DA
    Surg Clin North Am; 2011 Oct; 91(5):1039-77. PubMed ID: 21889029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.
    Park I; Ryu MH; Choi YH; Kang HJ; Yook JH; Park YS; Kim HJ; Jung HY; Lee GH; Kim KC; Kim BS; Kang YK
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):815-23. PubMed ID: 23921575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Chemotherapy and Radiation Therapy in the Management of Gastric Adenocarcinoma.
    Spiegel D; Palta M; Uronis H
    Surg Clin North Am; 2017 Apr; 97(2):421-435. PubMed ID: 28325195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
    Davidson M; Chau I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagogastric junction and gastric adenocarcinoma: neoadjuvant and adjuvant therapy, and future directions.
    Sandler S
    Oncology (Williston Park); 2014 Jun; 28(6):505-12. PubMed ID: 25134325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for gastric adenocarcinoma in Japan.
    Kodera Y
    Surg Today; 2017 Aug; 47(8):899-907. PubMed ID: 28247105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal treatment in locally advanced gastric cancer.
    Goetze OT; Al-Batran SE; Chevallay M; Mönig SP
    Updates Surg; 2018 Jun; 70(2):173-179. PubMed ID: 29946806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
    Cohen DJ; Leichman L
    J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy.
    Valenti V; Hernandez-Lizoaín JL; Beorlegui MC; Diaz-Gozalez JA; Regueira FM; Rodriguez JJ; Viudez A; Sola I; Cienfuegos JA
    J Surg Oncol; 2011 Aug; 104(2):124-9. PubMed ID: 21509785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
    Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of gastric cancer.
    Ku GY; Ilson DH
    Curr Opin Gastroenterol; 2014 Nov; 30(6):596-602. PubMed ID: 25197781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the Management of Gastric and Gastroesophageal Cancers.
    Kamran SC; Hong TS; Wo JY
    Curr Oncol Rep; 2016 Feb; 18(2):13. PubMed ID: 26769118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
    Ausch C; Rosen HR; Schiessel R
    Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of patients with gastric adenocarcinoma.
    Foukakis T; Lundell L; Gubanski M; Lind PA
    Acta Oncol; 2007; 46(3):277-85. PubMed ID: 17450463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy for gastric cancer: current and future directions.
    Foo M; Leong T
    World J Gastroenterol; 2014 Oct; 20(38):13718-27. PubMed ID: 25320509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States.
    Sherman KL; Merkow RP; Bilimoria KY; Wang CE; Mulcahy MF; Benson AB; Bentrem DJ
    Ann Surg Oncol; 2013 Feb; 20(2):362-70. PubMed ID: 22890592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoption of evidence-based novel therapies in the treatment of gastric cancer: A national observational study.
    Mokdad AA; Ali A; Yopp AC; Polanco PM; Nassour I; Mansour JC; Choti MA; Minter RM; Wang SC; Porembka MR
    Cancer; 2018 Mar; 124(6):1122-1131. PubMed ID: 29211302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy.
    Badgwell B; Das P; Ajani J
    J Hematol Oncol; 2017 Aug; 10(1):149. PubMed ID: 28810883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.